Thymoquinone (Tq) treatment suppresses the activation of MMPs via IL-7/AKT/NF-κB signaling that inhibits IL-7-induced tumor progression and metastatic invasion in DU145 cells [82]. The gene discussed is NFKB1; the disease is neoplasm.